Clinical trial NCT07093138
Status: RecruitingPhase 4Latest change: Source: ClinicalTrials.gov
What's on this page?
Information in the record
Original title: Evaluation of Efficacy and Safety of Topical Cannabidiol (Canvert-M Produced by Alasht Pharmed co. Iran) in the Treatment of Migraine Attacks
- Record number
- NCT07093138
- Status
- Recruiting
- Type and phase
- Clinical trial, phase 4
- Participants
- Target: 30
- Condition (as registered)
- Migraine Disorders
- Countries
- Iran
- Topic in the guide
- CBD Cream (Topical), Migraine
Timeline
According to the ClinicalTrials.gov record. Future dates are the investigator’s estimates and may change.
- Start: July 16, 2025
- End of data collection for primary results: September 16, 2025
- Trial completion: September 16, 2025
History
We check the record every day; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Recruiting.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · CBD Cream (Topical): ongoing trials · Migraine: ongoing trials · Thinking of taking part? Which specialist to see